|
End-of-day quote
Nasdaq
2024-02-05
|
5-day change | 1st Jan Change | ||
| 0.3222 USD | -2.36% |
|
+2.32% | -20.05% |
| 08-18 | Tonix Pharmaceuticals Holding Corp. Announces Appointment of Seth Lederman as Interim Chief Medical Officer | CI |
| 08-10 | Tonix Pharmaceuticals Holding Corp., Q2 2026 Earnings Call, Aug 10, 2026 |
Upcoming events on Tonix Pharmaceuticals
No events available
Past events on Tonix Pharmaceuticals
| 2026-08-10 | Earnings release - Q2 2026 | |
| 2026-08-10 | Earnings presentation | 08:30 |
| 2026-05-07 | Annual General Meeting | 11:00 |
| 2026-05-07 | Présentation aux Actionnaires / Analystes | 11:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,77 10,3 -24.56% | 10,1 13,0 -22.05% | 13,1 10,4 25.63% | 56,0 | 116 | 205 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -118 -118 -0.45% | -137 -135 -1.19% | -126 -113 -11.43% | -176 | -153 | -94,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -117 -119 1.89% | -130 -127 -2.71% | -124 -113 -9.95% | -173 | -153 | -80,2 |
|
Net income Million USD | Released Forecast Spread | -117 -115 -1.05% | -130 -127 -2.71% | -124 -112 -10.78% | -168 | -153 | -80,2 |
|
EPS USD | Released Forecast Spread | -21 920 -26 784 18.16% | -177 -137 -28.57% | -14,6 -13,4 -9.08% | -9,71 | -6,16 | -2,22 |
| Announcement Date | 01/04/24 | 18/03/25 | 12/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,58 3,35 -22.93% | 2,43 2,55 -4.75% | 2,00 2,43 -17.89% | 3,29 2,30 43.04% | 5,39 2,97 81.69% | 6,88 6,95 -1.04% | 13,5 7,72 75.38% | 16,2 | 19,6 | 21,6 | 25,8 | 30,2 | 33,4 |
|
EBIT Million USD | Released Forecast Spread | -22,5 -20,9 -7.56% | -16,1 -20,2 20.52% | -28,3 -22,9 -23.83% | -33,1 -28,5 -16.02% | -48,3 -35,4 -36.4% | -41,5 -39,2 -5.96% | -42,5 -42,1 -1.07% | -44,9 | -45,8 | -49,4 | -45,7 | -42,6 | -40,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,1 -18,7 -18.22% | -16,8 -20,2 16.69% | -28,3 -26,3 -7.5% | -32,0 -28,5 -12.32% | -46,9 -35,7 -31.4% | -40,2 -38,3 -5.08% | -40,6 -42,0 3.37% | -45,9 | -46,2 | -49,4 | -45,7 | -42,6 | -40,9 |
|
Net income Million USD | Released Forecast Spread | -22,1 -18,7 -18.22% | -16,8 -20,2 16.69% | -28,3 -26,3 -7.5% | -32,0 -28,5 -12.32% | -46,9 -34,9 -34.61% | -40,2 -38,3 -5.08% | -40,6 -42,0 3.37% | -45,9 | -46,2 | -49,4 | -45,7 | -42,6 | -40,9 |
|
EPS USD | Released Forecast Spread | -9,77 -6,23 -56.82% | -2,84 -3,23 12.07% | -3,86 -3,22 -20.06% | -3,59 -3,59 -0.14% | -3,98 -3,16 -25.95% | -2,93 -2,43 -20.41% | -2,44 -2,71 9.96% | -2,59 | -2,23 | -2,12 | -1,93 | -1,76 | -1,46 |
| Announcement Date | 18/03/25 | 12/05/25 | 11/08/25 | 10/11/25 | 12/03/26 | 11/05/26 | 10/08/26 | - | - | - | - | - | - |
| 2026-08-30 |  | Board of Directors Meeting | |
| 2026-08-30 | | Extraordinary General Meeting | |
| 2026-08-30 | | Présentation aux Actionnaires / Analystes | 23:00 |
| 2026-08-30 | | Board of Directors Meeting | |
| 2026-08-31 | | Earnings release - Q2 2026 | |
| 2026-08-31 | | Significant Split/Dividend | 00:00 |
| 2026-08-31 | | Earnings release - Q2 2026 | |
| 2026-08-31 | | Earnings release - Q2 2026 | |
| 2026-08-31 | | Significant Split/Dividend | 00:00 |
| 2026-08-31 | | Ex-dividend date - 2.56532 TWD | 00:00 |
Past sector events for Tonix Pharmaceuticals
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- TNXP Stock
- TNXP Stock
- Calendar Tonix Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
